Lenvatinib‐sensitive and lenvatinib‐resistant patient with HCC tissues were obtained and used to construct PDX models as previously described.[20] We overexpressed HECTD2 in lenvatinib‐sensitive PDX models and silenced HECTD2 in lenvatinib‐resistant models. This evidence concerns the gene HECTD2 and hepatocellular carcinoma.